Replies to post #15500 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

the prior dilution leading up to consolidation represents 6 fold (6x) dilution of Algernon since the reverse takeover back in 2018. to get to 54 Million share

dilution would be more than 25 fold (25x) dilution from the current outstanding. that's an insane amount of dilution given where the company currently sits with it's pending clinical trials. therefore, such dilution is highly not likely IF the company gets uplisted to Nasdaq. without an uplist, yeah we're all F'd!

also note - that 54.4 million number y'all are riffing about is not a real thing. it does not exist in the real world - in the official filings. one could also riff about the term "unlimited" authorized shares. yeah, theoretically you could issue a gadzillion shares but at some point reality sets in.

M$

[tcm55]

540k X $3 to $20 = $?

I would hope to see the Phase 1s (+) for SCLC and Stroke in process and a PPS over $20 before looking for a Private Placement.

Terrible handling of the PRs over the last months, we should be at $10 easily with keen interest in the company's progress. Inept sequences of the PRs Killed that sadly with a severe shareholder's ass kicking.

We need strong progress in the UK with the microdose of DMT trials for Stroke, ASAP... AND a partner/sponsor like the ACS for cancer tumors, ASAP. Could happen...GLTA...